Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice

Doxorubicin- (DOX-) related cardiac injury impairs the life quality of patients with cancer. This largely limited the clinical use of DOX. It is of great significance to find a novel strategy to reduce DOX-related cardiac injury. Oroxylin A (OA) has been identified to exert beneficial effects agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen-Bin, Zheng, Yong-Fa, Wu, Yao-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840263/
https://www.ncbi.nlm.nih.gov/pubmed/33542782
http://dx.doi.org/10.1155/2021/6610543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840263/
https://www.ncbi.nlm.nih.gov/pubmed/33542782
http://dx.doi.org/10.1155/2021/6610543

Ejemplares similares